Login / Signup

Probiotic Lactobacillus rhamnosus EM1107 prevents hyperglycemia, alveolar bone loss, and inflammation in a rat model of diabetes and periodontitis.

Davi Neto de Araújo SilvaNatália T S CruzAgnes A MartinsRégia Carla Medeiros da SilvaHursula C AlmeidaHeloísa E S CostaKarina M O SantosBasílio R VieiraFrederico Barbosa de SousaFrancisco Canindé de Sousa JúniorRaimundo F A JúniorGerlane C B GuerraFlavia Q PirihAurigena A AraújoAna Rafaela Luz de Aquino Martins
Published in: Journal of periodontology (2022)
The findings suggest the immunoinflammatory efficacy of the probiotic L. rhamnosus EM1107 administered either alone or in association with Met in type 1 DM associated with periodontitis.
Keyphrases
  • bone loss
  • lactic acid
  • glycemic control
  • bacillus subtilis
  • type diabetes
  • oxidative stress
  • cardiovascular disease
  • tyrosine kinase
  • mouse model
  • metabolic syndrome
  • adipose tissue
  • skeletal muscle